Hepatocellular carcinoma in patients with no identifiable risk factors.

[1]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[2]  C. la Vecchia,et al.  Worldwide incidence of hepatocellular carcinoma cases attributable to major risk factors , 2018, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[3]  H. El‐Serag,et al.  Incidence of Hepatocellular Carcinoma in All 50 United States, From 2000 Through 2012. , 2017, Gastroenterology.

[4]  P. Siersema,et al.  Hepatocellular carcinoma in cirrhotic versus noncirrhotic livers: results from a large cohort in the Netherlands , 2016, European journal of gastroenterology & hepatology.

[5]  H. El‐Serag,et al.  Hepatocellular Carcinoma in the Absence of Cirrhosis in United States Veterans is Associated With Nonalcoholic Fatty Liver Disease. , 2016, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[6]  Aijaz Ahmed,et al.  Pathogenesis of hepatocarcinogenesis in non-cirrhotic nonalcoholic fatty liver disease: Potential mechanistic pathways. , 2015, World journal of hepatology.

[7]  Y. Rotman,et al.  Emerging trends in hepatocellular carcinoma incidence and mortality , 2015, Hepatology.

[8]  A. Galli,et al.  Molecular mechanism of hepatitis B virus-induced hepatocarcinogenesis. , 2014, World journal of gastroenterology.

[9]  P. Malfertheiner,et al.  Characterization and prognosis of patients with hepatocellular carcinoma (HCC) in the non-cirrhotic liver , 2014, BMC Gastroenterology.

[10]  H. M. Reis,et al.  Pathogenic mechanisms in HBV- and HCV-associated hepatocellular carcinoma , 2013, Nature Reviews Cancer.

[11]  A. Young,et al.  Hepatocellular carcinoma within a noncirrhotic, nonfibrotic, seronegative liver: surgical approaches and outcomes. , 2012, Journal of the American College of Surgeons.

[12]  B. Graubard,et al.  Metabolic syndrome increases the risk of primary liver cancer in the United States: A study in the SEER‐medicare database , 2011, Hepatology.

[13]  M. Tretiakova,et al.  Genomic and immunophenotypical differences between hepatocellular carcinoma with and without cirrhosis , 2010, Histopathology.

[14]  H. El‐Serag,et al.  Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. , 2007, Gastroenterology.

[15]  Robert C. G. Martin,et al.  Kentucky hepatoma: epidemiologic variant or same problem in a different region? , 2007, Archives of surgery.

[16]  M. Choti,et al.  Differences in characteristics of patients with and without known risk factors for hepatocellular carcinoma in the United States. , 2007, World journal of gastroenterology.

[17]  M. Scotté,et al.  Long-Term Outcome of Liver Resection for Hepatocellular Carcinoma in Noncirrhotic Nonfibrotic Liver with No Viral Hepatitis or Alcohol Abuse , 2007, World Journal of Surgery.

[18]  K. Boudjema,et al.  Resection of hepatocellular carcinoma in noncirrhotic liver: analysis of risk factors for survival. , 2005, Journal of the American College of Surgeons.

[19]  C. Broelsch,et al.  Liver resection for hepatocellular carcinoma in non‐cirrhotic liver without underlying viral hepatitis , 2005, The British journal of surgery.

[20]  H. Bismuth,et al.  Surgical treatment of hepatocellular carcinomas in noncirrhotic liver: Experience with 68 liver resections , 2004, World Journal of Surgery.